On the other hand, myostatin is a potent inhibitor of muscle growth and is considered as a therapeutic target for muscle wasting including cachexia and sarcopenia, muscular dystrophy, and amyotrophic lateral sclerosis (Sakuma and Yamaguchi, 2011b). Here, MSTN is linked to sarcopenia.